Image Ben Hargreaves R&D Can China’s biotech industry weather frosty US relations? The Chinese biotech industry has grown rapidly to become a major hub of research. Oncology Reinvigorating the Cancer Moonshot with empowered patients The Biden administration has made various organisational and financial efforts to kick-start a renewed push against cancer. R&D A forgotten opioid epidemic, but a mounting problem Deaths from opioid-related overdoses continue to grow in the US, but public health events of recent times mean that attention has been focused elsewhere. Market Access Supply chains and the importance of transparency The pandemic revealed that global supply chains for the pharma industry are more fragile than expected. Load more results
R&D Can China’s biotech industry weather frosty US relations? The Chinese biotech industry has grown rapidly to become a major hub of research.
Oncology Reinvigorating the Cancer Moonshot with empowered patients The Biden administration has made various organisational and financial efforts to kick-start a renewed push against cancer.
R&D A forgotten opioid epidemic, but a mounting problem Deaths from opioid-related overdoses continue to grow in the US, but public health events of recent times mean that attention has been focused elsewhere.
Market Access Supply chains and the importance of transparency The pandemic revealed that global supply chains for the pharma industry are more fragile than expected.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
